ABCF1 is a hepatic oncofetal protein that modulates migration, epithelial–mesenchymal transition (EMT), and cancer stemness properties and is considered a novel potential therapeutic target for HCC treatment [54]. The gene discussed is ABCF1; the disease is cancer.